Amgen Inc - Change In Cash

Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Change-In-Cash" stands at 0.434 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Amgen Inc's third quarter result of 1.42 Billion USD for the item "Change In Cash" represents an increase of 281.20 percent compared to it's second quarter result.

Also, Amgen Inc's third quarter result of 1.42 Billion USD for the item "Change In Cash" represents an increase of 588.62 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Amgen Inc's third quarter result of 0.434 Billion USD for the item "Change In Cash" represents an increase of 134.09 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 26.16 Billion United States Dollars compared to the value the year prior.
The 1 year change is 26.16 Billion United States Dollars.
The 3 year change is 2.90 Billion United States Dollars.
The 5 year change is 2.76 Billion United States Dollars.
The 10 year change is 0.885 Billion United States Dollars.

The Serie's long term average value is 0.425 Billion United States Dollars. It's latest available value, on 09/30/2025, is 0.0088 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2024, to it's latest available value, on 09/30/2025, is +26.16 Billion.
The Serie's change in United States Dollars from it's maximum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is -28.61 Billion.